Comparison of Ultrasound Guided Intra-articular Steroid Injection and Pericapsular Nerve Group Block (PENG) in Patients With Chronic Hip Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hip Osteoarthritis
- Sponsor
- Diskapi Teaching and Research Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- numerical rating scale (NRS) pain score
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The most common cause of hip joint dysfunction in the elderly is degenerative osteoarthritis of the hip. Innervation of the hip joint capsule is provided by the obturator nerve, the accessory obturator nerve, and the femoral nerve. With pericapsular nerve group block (PENG), by blocking the femoral nerve and the accessory obturator nerve, analgesia is successfully provided for the hip joint. Intra-articular injection of corticosteroids; It is used as an alternative to surgical interventions because it reduces inflammation and short-term pain and is a minimally invasive method. The investigators aim to compare and report patients who underwent ultrasound-guided intra-articular steroid injection and PENG block in terms of post-procedural pain scores and patient satisfaction.
Investigators
Selin Guven Kose
principal Investigator
Diskapi Teaching and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Hip pain NRS \> 4
- •No pathologies in the laboratory and coagulation parameters
Exclusion Criteria
- •Rheumatological disease with hip involvement
- •Systemic active infection
- •Malignancy
- •History of hip joint surgery
- •History of traumatic hip injury
- •Platelets values \< 150.000 / µl
- •History of bleeding disorder
Outcomes
Primary Outcomes
numerical rating scale (NRS) pain score
Time Frame: change from baseline to day 1, week 2, 4, 8 after the block
The 11-point NRS consists of numbers between 0 and 10 where 0 indicates "no pain" and 10 indicates "maximum pain." The patient is instructed to identify one number between 0 and 10, which is best representative of their pain intensity.
Secondary Outcomes
- Quality of Life (WOMAC)(baseline to 8 weeks)